Keyphrases
Melanoma
100%
Clinical Response
100%
Vaccinium
100%
Serological Response
100%
Melanoma Cells
40%
Disease-free Survival
40%
Anti-melanoma
40%
Cell Membrane
20%
Neoadjuvant Setting
20%
Virus
20%
Statistical Comparison
20%
Melanoma Patients
20%
Enzyme-linked Immunosorbent Assay (ELISA)
20%
No Evidence of Disease
20%
Staphylococcal Protein A
20%
Surgical Adjuvants
20%
Intradermal Injection
20%
Booster Injection
20%
Rosette
20%
IgG Antibody Titer
20%
Smallpox
20%
High-risk Melanoma
20%
Pharmacology, Toxicology and Pharmaceutical Science
Melanoma
100%
Vaccinia Oncolysate
100%
Disease Free Survival
50%
Disease
25%
Enzyme-Linked Immunosorbent Assay
25%
Recurrent Disease
25%
Immunoglobulin G Antibody
25%
Staphylococcus Protein A
25%
Smallpox
25%
Immunology and Microbiology
Medicine and Dentistry
Staphylococcus Protein A
25%